Studies have shown that a specific non-drug treatment of cognitive behavioral therapy (CBT) developed by researchers at the Jacobs School of Medicine and Biomedical Sciences can be effective for a range of pain problems and lead to significant improvements in functioning, quality of life and symptoms resistant to medical treatments.
Fifteen faculty members and three staff members from the Jacobs School of Medicine and Biomedical Sciences were among those honored for notable achievements and service at the 19th annual University at Buffalo Celebration of Faculty and Staff Academic Excellence.
The University at Buffalo is one of five universities nationwide that has been awarded an important grant from the Association of American Medical Colleges (AAMC) that supports teaching health sciences students how to dispel medical disinformation.
UB is sponsoring a virtual talk on “The COVID-19 Vaccines: Science vs. Anti-science” by prominent vaccine scientist and “misinformation antagonist” Peter J. Hotez, MD, PhD, on June 9 at noon.
A University at Buffalo expert on the behavioral treatment of chronic pain disorders has been awarded $3.3 million from the National Institutes of Health to conduct a five-year clinical study of drug-free behavioral treatments for chronic pelvic pain in men and women.
Jeffrey M. Lackner, PsyD, professor of medicine and chief of the Division of Behavioral Medicine, has been elected to the Academy of Behavioral Medicine Research (ABMR).
